Michaelis, M., & Deimling, A. v. (2020). Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines. Cancers, 12(3), . https://doi.org/10.3390/cancers12030577
Chicago Style (17th ed.) CitationMichaelis, Martin, and Andreas von Deimling. "Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-resistant Neuroblastoma Cell Lines." Cancers 12, no. 3 (2020). https://doi.org/10.3390/cancers12030577.
MLA (9th ed.) CitationMichaelis, Martin, and Andreas von Deimling. "Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-resistant Neuroblastoma Cell Lines." Cancers, vol. 12, no. 3, 2020, https://doi.org/10.3390/cancers12030577.
Warning: These citations may not always be 100% accurate.